J&J Announces $1 Billion Agreement To Supply 100 Million Doses Of Investigational COVID-19 Vaccine

On August 5, 2020, Johnson & Johnson (J&J) announced that its Janssen Pharmaceutical Companies had reached an agreement with the U.S. Department of Health and Human Services (HHS) and Department of Defense (DoD) to supply 100 million doses of an investigational vaccine for coronavirus disease 2019 (COVID-19) for use in the United States. Under the agreement, Janssen will demonstrate large-scale manufacturing and delivery of the company's COVID-19 vaccine candidate Ad26.COV2.S.

HHS said this manufacturing demonstration project will take place while clinical trials are underway. Working in parallel this way expedites the . . .